Form 4: CompoSecure Director Brian Hughes Receives Significant Stock Option Grant
Insider Transaction Report
CompoSecure, Inc. Director Brian F. Hughes was granted 21,074 stock options with an exercise price of $13.68, vesting annually over four years, as disclosed in a recent Form 4 filing.
Summary
- Brian F. Hughes, a Director of CompoSecure, Inc. (CMPO), was granted 21,074 stock options.
- The options have an exercise price of $13.68 per share.
- The transaction date for this grant was May 28, 2025.
- The stock options will vest in equal annual installments of 25% each on May 28, 2026, and on the first, second, and third anniversaries thereof (May 28, 2027, May 28, 2028, and May 28, 2029).
- The options have an expiration date of May 28, 2035.
- Following this transaction, Brian F. Hughes beneficially owns 21,074 derivative securities directly.
Sentiment
Score: 7
Explanation: The sentiment is generally positive as it represents a standard equity grant that aligns management incentives with shareholder value. It is not highly impactful on its own but reflects ongoing corporate governance practices.
Positives
- The grant of stock options aligns the interests of Director Brian F. Hughes with those of CompoSecure shareholders, incentivizing long-term company performance.
- Equity compensation is a standard practice for retaining and motivating key personnel, indicating a commitment to strong leadership.
Negatives
- No specific negative implications are directly apparent from this standard equity grant.
Risks
- The value of the stock options is subject to the future performance of CompoSecure's stock price; if the stock price does not exceed the exercise price of $13.68, the options may not be 'in the money' and could expire worthless.
Future Outlook
The vesting schedule of the stock options over the next four years indicates a long-term incentive structure for Director Brian F. Hughes, aligning his future financial interests with the sustained growth and performance of CompoSecure, Inc.
Industry Context
The granting of stock options to directors is a common and widely accepted practice across various industries, particularly in technology and growth-oriented companies, as a means of executive compensation and to foster alignment between leadership and shareholder interests.
Comparison to Industry Standards
- The structure of this equity grant, including the vesting schedule and option type, is consistent with typical executive compensation packages observed in the broader technology and financial services industries for companies of similar size and growth stage.
- While specific comparable companies are not named in the filing, similar equity incentive plans are prevalent at firms like Visa, Mastercard, and other fintech companies, which often use stock options or restricted stock units to compensate and retain key executives and directors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Implementation | The grant of stock options to a director is an implementation of the company's existing compensation policy, designed to incentivize long-term performance and align management interests with shareholder value. | 05/28/2025 | This action reinforces the company's commitment to performance-based compensation and strengthens the alignment between the director's financial interests and the company's stock performance. |
Related Party Transactions
- The grant of stock options to Brian F. Hughes, a Director of CompoSecure, Inc., constitutes a related party transaction as it involves compensation provided to an insider of the company.
Stakeholder Impact
- **Shareholders:** The grant aims to align the director's interests with shareholders by incentivizing stock price appreciation, potentially leading to better long-term performance.
- **Employees:** While not directly impacting all employees, such grants are part of a broader compensation philosophy that can influence overall company culture and talent retention strategies.
- **Director (Brian F. Hughes):** Receives a significant equity incentive, providing a direct financial stake in the company's future success.
Next Steps
- The stock options will vest in annual installments, with the first vesting on May 28, 2026.
- Director Brian F. Hughes may choose to exercise the vested options at any time before their expiration on May 28, 2035, subject to company policy and market conditions.
Key Dates
| Date | Description |
|---|---|
| 05/28/2025 | Date of stock option grant transaction. |
| 05/28/2026 | First 25% vesting date for the stock options. |
| 05/28/2027 | Second 25% vesting date for the stock options. |
| 05/28/2028 | Third 25% vesting date for the stock options. |
| 05/28/2029 | Fourth and final 25% vesting date for the stock options. |
| 05/30/2025 | Date the Form 4 filing was signed and submitted. |
| 05/28/2035 | Expiration date of the stock options. |
Keywords
CompoSecure, CMPO, Stock Options, Equity Grant, Director Compensation, Form 4, Insider Transaction, Brian F. Hughes, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.